Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
NPJ Breast Cancer|September 1, 2021
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibitionDiar Aziz, Neil Portman, Kristine J Fernandez, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastomaHolly Holliday, Jessica Yang, Eoin Dodson, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 5, 2019
Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and CancerNicola Currey, Zeenat Jahan, C Elizabeth Caldon, et al.
Molecular Cancer|January 8, 2026
BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in transHaran Sivakumaran, Sneha Nair, Mainá Bitar, et al.
Nature Communications|January 18, 2020
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancerJoanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 18, 2025
JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancerSarah Alexandrou, Christine S Lee, Kristine J Fernandez, et al.
Oncogene|May 11, 2018
MASTL overexpression promotes chromosome instability and metastasis in breast cancerSamuel Rogers, Rachael A McCloy, Benjamin L Parker, et al.
Pageof 5